Breighner Robert G. JR 4

What Happened
Robert G. Breighner Jr., Senior Vice President of Select Medical Holdings Corp. (SEM), had 34,696 company shares affected as part of the merger closing on 2026-06-30. He disposed 18,362 shares to the issuer at $16.50 per share for $302,973 in cash, and contributed/rolled 16,334 restricted shares (no cash received) into the buyer under the Merger Agreement.

Key Details

• Transaction date: 2026-06-30; Form 4 filed 2026-07-01 (timely filing).
• Cash disposition: 18,362 shares × $16.50 = $302,973.
• Rollover: 16,334 restricted shares were contributed to Stallion Intermediate Corporation and converted into Parent equity/interests (reported as a J-code disposition with $0 cash).
• Footnotes: (F1–F4) Transactions occurred under the March 2, 2026 Merger Agreement; Rollover Shares were exchanged for Parent common/LP interests; other restricted shares vested immediately prior to the merger and converted into the $16.50-per-share Merger Consideration (net of any applicable tax withholdings).
• Transaction codes: J = other acquisition/disposition (rollover into buyer); D = disposition to issuer (cash conversion).
• Shares owned after the reported transactions: not disclosed on the Form 4.

Context
These actions were merger-related (conversion of equity and rollover into the buyer) rather than open-market trades. The cash payment reflects the merger consideration of $16.50 per share; some cash proceeds from converted restricted shares may have been reduced by tax withholding per the filing. Such M&A-driven dispositions/rollovers are common in buyouts and do not necessarily reflect a standalone trading signal.